BASF's Valuation Puzzle: Agri Spinoff Could Be Worth Half the Company, but Operations Remain Under Pressure

Investors weigh BASF's valuation puzzle as its Ag division IPO could be worth €20-30B, more than half of current market cap, but operational issues and missed guidance linger.

Investors in BASF are weighing an extraordinary valuation conundrum. The chemicals giant's agricultural division – which generates roughly a sixth of group sales – could command a market value of €20 billion to €30 billion when a minority stake is floated in 2027. That would represent more than half of BASF's entire current market capitalisation of €42.05 billion, leaving the rest of the conglomerate valued at a fraction of its potential. The arithmetic has sparked fresh interest in a stock that only last November was trading at a 52-week low of €41.60.

The share price has responded accordingly. After closing at €48.62 on the previous session, BASF shares rose 2.25% on the day to €49.71, bringing the week's gain to 4.87% and the year-to-date advance to 11.11%. The rally has been fuelled by two distinct catalysts: the IPO roadshow and a broader tailwind for European chemical stocks linked to rising oil prices. Brent crude climbing to around $85 a barrel, prompted by the US announcement of a naval blockade amid the escalating Iran conflict, has lifted peers such as Wacker Chemie and K+S. Analysts argue that BASF can pass on higher raw material costs to customers, a point reinforced by CFO Elvermann, who voiced confidence in the company's ability to navigate the crisis.

Yet beneath the headline optimism, operational frictions remain evident. On July 9, an unplanned disruption hit the main Ludwigshafen complex, where the wastewater treatment plant suffered a partial failure of its nitrification function, causing elevated ammonium nitrogen levels in the Rhine. BASF insists there is no direct danger to people, but the incident underscores how sensitive production at the sprawling site can be – and how quickly cost pressures can resurface. The group already missed its 2025 guidance, reporting adjusted EBITDA of €6.6 billion against a target range of €6.7-7.1 billion. For the third quarter of 2026, net profit is expected to dip noticeably, and management has outlined annual cost savings of €500 million, partly through shifting service functions to India.

The IPO itself is still two years away, and the exact timing depends on market conditions. Shareholders have approved the carve-out, and BASF has contacted banks to prepare the listing of a minority stake in Frankfurt. Until 2027, the group carries the full weight of volatile agricultural markets and high German energy costs on its own. A quarterly report due on July 29 will provide the next reality check, with investors focused on margins in the industrial segment and any fresh clues on the disposal timeline.

Technically, the recovery has taken the stock back within striking distance of its 52-week high of €55.05, set on April 14, 2026 – a gap of just 9.70%. The share price now sits 4.63% above its 200-day moving average of €47.51, while the 50-day moving average at €49.85 lies only marginally above the current level. The relative strength index of 58.8 suggests no overbought conditions yet, and annualised volatility of roughly 22% remains moderate. The dividend for the past financial year of €2.25 per share adds another layer of support for value-oriented holders.

Bearish observers point to the risk of technical selling if the stock slips back below the 200-day average, and the Ludwigshafen glitch could compound cost headwinds at a time when the rest of the chemical industry is also grappling with structural change. Calls from politicians and union leaders for a slower transformation of Europe's industrial base, as echoed by Lower Saxony's premier and IG BCE representatives in a recent Handelsblatt op-ed, highlight the broader debate BASF cannot escape. On the brighter side, a cooperation with NGK Insulators on next-generation sodium-sulphur batteries for grid storage signals the company is not standing still on innovation.

For now, the market is betting that the sum-of-the-parts logic will prevail. If the agricultural division can achieve even the lower end of the €20-30 billion valuation band, the remaining industrial businesses – global leaders in several chemical segments – would be left with a market tag of only €12-22 billion, a potential magnet for bargain hunters. The path to that re-rating, however, runs through two years of operational discipline, cost control, and a clean bill of health from the Ludwigshafen plant. The next few weeks will show whether the IPO narrative alone can sustain the momentum.